><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Divangahi</surname><given-names>M</given-names></name><name><surname>King</surname><given-names>IL</given-names></name><name><surname>Pernet</surname><given-names>E</given-names></name></person-group>. <article-title>Alveolar macrophages and type I IFN in airway homeostasis and immunity</article-title>. <source>Trends Immunol</source> (<year>2015</year>) <volume>36</volume>:<fpage>307</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1016/j.it.2015.03.005</pub-id><?supplied-pmid 25843635?><pub-id pub-id-type="pmid">25843635</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotas</surname><given-names>ME</given-names></name><name><surname>Medzhitov</surname><given-names>R</given-names></name></person-group>
<article-title>Homeostasis, inflammation, and disease susceptibility</article-title>. <source>Cell</source> (<year>2015</year>) <volume>26</volume>(<issue>160</issue>):<fpage>816</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2015.02.010</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medzhitov</surname><given-names>R</given-names></name><name><surname>Schneider</surname><given-names>DS</given-names></name><name><surname>Soares</surname><given-names>MP</given-names></name></person-group>
<article-title>Disease tolerance as a defense strategy</article-title>. <source>Science</source> (<year>2012</year>) <volume>24</volume>(<issue>335</issue>):<fpage>936</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1126/science.1214935</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soares</surname><given-names>MP</given-names></name><name><surname>Gozzelino</surname><given-names>R</given-names></name><name><surname>Weis</surname><given-names>S</given-names></name></person-group>. <article-title>Tissue damage control in disease tolerance</article-title>. <source>Trends Immunol</source> (<year>2014</year>) <volume>35</volume>:<fpage>483</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1016/j.it.2014.08.001</pub-id><?supplied-pmid 25182198?><pub-id pub-id-type="pmid">25182198</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buckley</surname><given-names>CD</given-names></name><name><surname>Gilroy</surname><given-names>DW</given-names></name><name><surname>Serhan</surname><given-names>CN</given-names></name></person-group>. <article-title>Proresolving lipid mediators and mechanisms in the resolution of acute inflammation</article-title>. <source>Immunity</source> (<year>2014</year>) <volume>20</volume>(<issue>40</issue>):<fpage>315</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2014.02.009</pub-id><?supplied-pmid 24656045?><pub-id pub-id-type="pmid">24656045</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dudakov</surname><given-names>JA</given-names></name><name><surname>Hanash</surname><given-names>AM</given-names></name><name><surname>van den Brink</surname><given-names>MR</given-names></name></person-group>. <article-title>Interleukin-22: immunobiology and pathology</article-title>. <source>Annu Rev Immunol</source> (<year>2015</year>) <volume>33</volume>:<fpage>747</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="doi">10.1146/annurev-immunol-032414-112123</pub-id><?supplied-pmid 25706098?><pub-id pub-id-type="pmid">25706098</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wynn</surname><given-names>TA</given-names></name><name><surname>Vannella</surname><given-names>KM</given-names></name></person-group>
<article-title>Macrophages in tissue repair, regeneration, and fibrosis</article-title>. <source>Immunity</source> (<year>2016</year>) <volume>15</volume>(<issue>44</issue>):<fpage>450</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2016.02.015</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaiss</surname><given-names>DM</given-names></name><name><surname>Gause</surname><given-names>WC</given-names></name><name><surname>Osborne</surname><given-names>LC</given-names></name><name><surname>Artis</surname><given-names>D</given-names></name></person-group>. <article-title>Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair</article-title>. <source>Immunity</source> (<year>2015</year>) <volume>17</volume>(<issue>42</issue>):<fpage>216</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2015.01.020</pub-id><?supplied-pmid 25692699?><pub-id pub-id-type="pmid">25692699</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castiglia</surname><given-names>V</given-names></name><name><surname>Piersigilli</surname><given-names>A</given-names></name><name><surname>Ebner</surname><given-names>F</given-names></name><name><surname>Janos</surname><given-names>M</given-names></name><name><surname>Goldmann</surname><given-names>O</given-names></name><name><surname>Dambock</surname><given-names>U</given-names></name><etal/></person-group>
<article-title>Type I interferon signaling prevents IL-1beta-driven lethal systemic hyperinflammation during invasive bacterial infection of soft tissue</article-title>. <source>Cell Host Microbe</source> (<year>2016</year>) <volume>9</volume>(<issue>19</issue>):<fpage>375</fpage>&#x02013;<lpage>87</lpage>.<pub-id pub-id-type="doi">10.1016/j.chom.2016.02.003</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LeMessurier</surname><given-names>KS</given-names></name><name><surname>Hacker</surname><given-names>H</given-names></name><name><surname>Chi</surname><given-names>L</given-names></name><name><surname>Tuomanen</surname><given-names>E</given-names></name><name><surname>Redecke</surname><given-names>V</given-names></name></person-group>. <article-title>Type I interferon protects against pneumococcal invasive disease by inhibiting bacterial transmigration across the lung</article-title>. <source>PLoS Pathog</source> (<year>2013</year>) <volume>9</volume>:<fpage>e1003727</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1003727</pub-id><?supplied-pmid 24244159?><pub-id pub-id-type="pmid">24244159</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maier</surname><given-names>BB</given-names></name><name><surname>Hladik</surname><given-names>A</given-names></name><name><surname>Lakovits</surname><given-names>K</given-names></name><name><surname>Korosec</surname><given-names>A</given-names></name><name><surname>Martins</surname><given-names>R</given-names></name><name><surname>Kral</surname><given-names>JB</given-names></name><etal/></person-group>
<article-title>Type I interferon promotes alveolar epithelial type II cell survival during pulmonary <italic>Streptococcus pneumoniae</italic> infection and sterile lung injury in mice</article-title>. <source>Eur J Immunol</source> (<year>2016</year>) <volume>46</volume>:<fpage>2175</fpage>&#x02013;<lpage>86</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201546201</pub-id><?supplied-pmid 27312374?><pub-id pub-id-type="pmid">27312374</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boxx</surname><given-names>GM</given-names></name><name><surname>Cheng</surname><given-names>G</given-names></name></person-group>
<article-title>The roles of type I interferon in bacterial infection</article-title>. <source>Cell Host Microbe</source> (<year>2016</year>) <volume>8</volume>(<issue>19</issue>):<fpage>760</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.chom.2016.05.016</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNab</surname><given-names>F</given-names></name><name><surname>Mayer-Barber</surname><given-names>K</given-names></name><name><surname>Sher</surname><given-names>A</given-names></name><name><surname>Wack</surname><given-names>A</given-names></name><name><surname>O&#x02019;Garra</surname><given-names>A</given-names></name></person-group>
<article-title>Type I interferons in infectious disease</article-title>. <source>Nat Rev Immunol</source> (<year>2015</year>) <volume>15</volume>:<fpage>87</fpage>&#x02013;<lpage>103</lpage>.<pub-id pub-id-type="doi">10.1038/nri3787</pub-id><pub-id pub-id-type="pmid">25614319</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname><given-names>D</given-names></name><name><surname>Planet</surname><given-names>PJ</given-names></name><name><surname>Soong</surname><given-names>G</given-names></name><name><surname>Narechania</surname><given-names>A</given-names></name><name><surname>Prince</surname><given-names>A</given-names></name></person-group>. <article-title>Induction of type I interferon signaling determines the relative pathogenicity of <italic>Staphylococcus aureus</italic> strains</article-title>. <source>PLoS Pathog</source> (<year>2014</year>) <volume>10</volume>:<fpage>e1003951</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1003951</pub-id><?supplied-pmid 24586160?><pub-id pub-id-type="pmid">24586160</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gratz</surname><given-names>N</given-names></name><name><surname>Hartweger</surname><given-names>H</given-names></name><name><surname>Matt</surname><given-names>U</given-names></name><name><surname>Kratochvill</surname><given-names>F</given-names></name><name><surname>Janos</surname><given-names>M</given-names></name><name><surname>Sigel</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Type I interferon production induced by <italic>Streptococcus pyogenes</italic>-derived nucleic acids is required for host protection</article-title>. <source>PLoS Pathog</source> (<year>2011</year>) <volume>7</volume>:<fpage>e1001345</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1001345</pub-id><?supplied-pmid 21625574?><pub-id pub-id-type="pmid">21625574</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mancuso</surname><given-names>G</given-names></name><name><surname>Midiri</surname><given-names>A</given-names></name><name><surname>Biondo</surname><given-names>C</given-names></name><name><surname>Beninati</surname><given-names>C</given-names></name><name><surname>Zummo</surname><given-names>S</given-names></name><name><surname>Galbo</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>1</volume>(<issue>178</issue>):<fpage>3126</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.178.5.3126</pub-id><?supplied-pmid 17312160?><pub-id pub-id-type="pmid">17312160</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mancuso</surname><given-names>G</given-names></name><name><surname>Gambuzza</surname><given-names>M</given-names></name><name><surname>Midiri</surname><given-names>A</given-names></name><name><surname>Biondo</surname><given-names>C</given-names></name><name><surname>Papasergi</surname><given-names>S</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells</article-title>. <source>Nat Immunol</source> (<year>2009</year>) <volume>10</volume>:<fpage>587</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1038/ni.1733</pub-id><?supplied-pmid 19430477?><pub-id pub-id-type="pmid">19430477</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lippmann</surname><given-names>J</given-names></name><name><surname>Muller</surname><given-names>HC</given-names></name><name><surname>Naujoks</surname><given-names>J</given-names></name><name><surname>Tabeling</surname><given-names>C</given-names></name><name><surname>Shin</surname><given-names>S</given-names></name><name><surname>Witzenrath</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Dissection of a type I interferon pathway in controlling bacterial intracellular infection in mice</article-title>. <source>Cell Microbiol</source> (<year>2011</year>) <volume>13</volume>:<fpage>1668</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1111/j.1462-5822.2011.01646.x</pub-id><?supplied-pmid 21790939?><pub-id pub-id-type="pmid">21790939</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naujoks</surname><given-names>J</given-names></name><name><surname>Tabeling</surname><given-names>C</given-names></name><name><surname>Dill</surname><given-names>BD</given-names></name><name><surname>Hoffmann</surname><given-names>C</given-names></name><name><surname>Brown</surname><given-names>AS</given-names></name><name><surname>Kunze</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>IFNs modify the proteome of <italic>Legionella</italic>-containing vacuoles and restrict infection via IRG1-derived itaconic acid</article-title>. <source>PLoS Pathog</source> (<year>2016</year>) <volume>12</volume>:<fpage>e1005408</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1005408</pub-id><?supplied-pmid 26829557?><pub-id pub-id-type="pmid">26829557</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Asano</surname><given-names>N</given-names></name><name><surname>Fichtner-Feigl</surname><given-names>S</given-names></name><name><surname>Gorelick</surname><given-names>PL</given-names></name><name><surname>Tsuji</surname><given-names>Y</given-names></name><name><surname>Matsumoto</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>NOD1 contributes to mouse host defense against <italic>Helicobacter pylori</italic> via induction of type I IFN and activation of the ISGF3 signaling pathway</article-title>. <source>J Clin Invest</source> (<year>2010</year>) <volume>120</volume>:<fpage>1645</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1172/JCI39481</pub-id><?supplied-pmid 20389019?><pub-id pub-id-type="pmid">20389019</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>FJ</given-names></name><name><surname>Gomez</surname><given-names>MI</given-names></name><name><surname>Wetzel</surname><given-names>DM</given-names></name><name><surname>Memmi</surname><given-names>G</given-names></name><name><surname>O&#x02019;Seaghdha</surname><given-names>M</given-names></name><name><surname>Soong</surname><given-names>G</given-names></name><etal/></person-group>
<article-title><italic>Staphylococcus aureus</italic> activates type I IFN signaling in mice and humans through the Xr repeated sequences of protein A</article-title>. <source>J Clin Invest</source> (<year>2009</year>) <volume>119</volume>:<fpage>1931</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1172/JCI35879</pub-id><?supplied-pmid 19603548?><pub-id pub-id-type="pmid">19603548</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manca</surname><given-names>C</given-names></name><name><surname>Tsenova</surname><given-names>L</given-names></name><name><surname>Freeman</surname><given-names>S</given-names></name><name><surname>Barczak</surname><given-names>AK</given-names></name><name><surname>Tovey</surname><given-names>M</given-names></name><name><surname>Murray</surname><given-names>PJ</given-names></name><etal/></person-group>
<article-title>Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway</article-title>. <source>J Interferon Cytokine Res</source> (<year>2005</year>) <volume>25</volume>:<fpage>694</fpage>&#x02013;<lpage>701</lpage>.<pub-id pub-id-type="doi">10.1089/jir.2005.25.694</pub-id><?supplied-pmid 16318583?><pub-id pub-id-type="pmid">16318583</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanley</surname><given-names>SA</given-names></name><name><surname>Johndrow</surname><given-names>JE</given-names></name><name><surname>Manzanillo</surname><given-names>P</given-names></name><name><surname>Cox</surname><given-names>JS</given-names></name></person-group>. <article-title>The Type I IFN response to infection with <italic>Mycobacterium tuberculosis</italic> requires ESX-1-mediated secretion and contributes to pathogenesis</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>178</volume>:<fpage>3143</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.178.5.3143</pub-id><?supplied-pmid 17312162?><pub-id pub-id-type="pmid">17312162</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name><name><surname>Andrade</surname><given-names>BB</given-names></name><name><surname>Barber</surname><given-names>DL</given-names></name><name><surname>Hieny</surname><given-names>S</given-names></name><name><surname>Feng</surname><given-names>CG</given-names></name><name><surname>Caspar</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Innate and adaptive interferons suppress IL-1alpha and IL-1beta production by distinct pulmonary myeloid subsets during <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>Immunity</source> (<year>2011</year>) <volume>23</volume>(<issue>35</issue>):<fpage>1023</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2011.12.002</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auerbuch</surname><given-names>V</given-names></name><name><surname>Brockstedt</surname><given-names>DG</given-names></name><name><surname>Meyer-Morse</surname><given-names>N</given-names></name><name><surname>O&#x02019;Riordan</surname><given-names>M</given-names></name><name><surname>Portnoy</surname><given-names>DA</given-names></name></person-group>. <article-title>Mice lacking the type I interferon receptor are resistant to <italic>Listeria monocytogenes</italic></article-title>. <source>J Exp Med</source> (<year>2004</year>) <volume>16</volume>(<issue>200</issue>):<fpage>527</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20040976</pub-id><?supplied-pmid 15302899?><pub-id pub-id-type="pmid">15302899</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Connell</surname><given-names>RM</given-names></name><name><surname>Saha</surname><given-names>SK</given-names></name><name><surname>Vaidya</surname><given-names>SA</given-names></name><name><surname>Bruhn</surname><given-names>KW</given-names></name><name><surname>Miranda</surname><given-names>GA</given-names></name><name><surname>Zarnegar</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Type I interferon production enhances susceptibility to <italic>Listeria monocytogenes</italic> infection</article-title>. <source>J Exp Med</source> (<year>2004</year>) <volume>16</volume>(<issue>200</issue>):<fpage>437</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20040712</pub-id><?supplied-pmid 15302901?><pub-id pub-id-type="pmid">15302901</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrero</surname><given-names>JA</given-names></name><name><surname>Calderon</surname><given-names>B</given-names></name><name><surname>Unanue</surname><given-names>ER</given-names></name></person-group>. <article-title>Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to <italic>Listeria</italic> infection</article-title>. <source>J Exp Med</source> (<year>2004</year>) <volume>16</volume>(<issue>200</issue>):<fpage>535</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20040769</pub-id><?supplied-pmid 15302900?><pub-id pub-id-type="pmid">15302900</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kernbauer</surname><given-names>E</given-names></name><name><surname>Maier</surname><given-names>V</given-names></name><name><surname>Rauch</surname><given-names>I</given-names></name><name><surname>Muller</surname><given-names>M</given-names></name><name><surname>Decker</surname><given-names>T</given-names></name></person-group>. <article-title>Route of infection determines the impact of type I interferons on innate immunity to <italic>Listeria monocytogenes</italic></article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>:<fpage>e65007</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0065007</pub-id><?supplied-pmid 23840314?><pub-id pub-id-type="pmid">23840314</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rayamajhi</surname><given-names>M</given-names></name><name><surname>Humann</surname><given-names>J</given-names></name><name><surname>Penheiter</surname><given-names>K</given-names></name><name><surname>Andreasen</surname><given-names>K</given-names></name><name><surname>Lenz</surname><given-names>LL</given-names></name></person-group>. <article-title>Induction of IFN-alphabeta enables <italic>Listeria monocytogenes</italic> to suppress macrophage activation by IFN-gamma</article-title>. <source>J Exp Med</source> (<year>2010</year>) <volume>15</volume>(<issue>207</issue>):<fpage>327</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20091746</pub-id><?supplied-pmid 20123961?><pub-id pub-id-type="pmid">20123961</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pitts</surname><given-names>MG</given-names></name><name><surname>Myers-Morales</surname><given-names>T</given-names></name><name><surname>D&#x02019;Orazio</surname><given-names>SE</given-names></name></person-group>. <article-title>Type I IFN does not promote susceptibility to foodborne <italic>Listeria monocytogenes</italic></article-title>. <source>J Immunol</source> (<year>2016</year>) <volume>1</volume>(<issue>196</issue>):<fpage>3109</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1502192</pub-id><?supplied-pmid 26895837?><pub-id pub-id-type="pmid">26895837</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henry</surname><given-names>T</given-names></name><name><surname>Kirimanjeswara</surname><given-names>GS</given-names></name><name><surname>Ruby</surname><given-names>T</given-names></name><name><surname>Jones</surname><given-names>JW</given-names></name><name><surname>Peng</surname><given-names>K</given-names></name><name><surname>Perret</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Type I IFN signaling constrains IL-17A/F secretion by gammadelta T cells during bacterial infections</article-title>. <source>J Immunol</source> (<year>2010</year>) <volume>1</volume>(<issue>184</issue>):<fpage>3755</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.0902065</pub-id><?supplied-pmid 20176744?><pub-id pub-id-type="pmid">20176744</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henry</surname><given-names>T</given-names></name><name><surname>Brotcke</surname><given-names>A</given-names></name><name><surname>Weiss</surname><given-names>DS</given-names></name><name><surname>Thompson</surname><given-names>LJ</given-names></name><name><surname>Monack</surname><given-names>DM</given-names></name></person-group>. <article-title>Type I interferon signaling is required for activation of the inflammasome during <italic>Francisella</italic> infection</article-title>. <source>J Exp Med</source> (<year>2007</year>) <volume>14</volume>(<issue>204</issue>):<fpage>987</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20062665</pub-id><?supplied-pmid 17452523?><pub-id pub-id-type="pmid">17452523</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>N</given-names></name><name><surname>McComb</surname><given-names>S</given-names></name><name><surname>Mulligan</surname><given-names>R</given-names></name><name><surname>Dudani</surname><given-names>R</given-names></name><name><surname>Krishnan</surname><given-names>L</given-names></name><name><surname>Sad</surname><given-names>S</given-names></name></person-group>. <article-title>Type I interferon induces necroptosis in macrophages during infection with <italic>Salmonella enterica</italic> serovar Typhimurium</article-title>. <source>Nat Immunol</source> (<year>2012</year>) <volume>13</volume>(<issue>10</issue>):<fpage>954</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1038/ni.2397</pub-id><?supplied-pmid 22922364?><pub-id pub-id-type="pmid">22922364</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perkins</surname><given-names>DJ</given-names></name><name><surname>Rajaiah</surname><given-names>R</given-names></name><name><surname>Tennant</surname><given-names>SM</given-names></name><name><surname>Ramachandran</surname><given-names>G</given-names></name><name><surname>Higginson</surname><given-names>EE</given-names></name><name><surname>Dyson</surname><given-names>TN</given-names></name><etal/></person-group>
<article-title><italic>Salmonella</italic> Typhimurium co-opts the host type I IFN system to restrict macrophage innate immune transcriptional responses selectively</article-title>. <source>J Immunol</source> (<year>2015</year>) <volume>1</volume>(<issue>195</issue>):<fpage>2461</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1500105</pub-id><?supplied-pmid 26202980?><pub-id pub-id-type="pmid">26202980</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hedges</surname><given-names>JF</given-names></name><name><surname>Robison</surname><given-names>A</given-names></name><name><surname>Kimmel</surname><given-names>E</given-names></name><name><surname>Christensen</surname><given-names>K</given-names></name><name><surname>Lucas</surname><given-names>E</given-names></name><name><surname>Ramstead</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Type I interferon counters or promotes <italic>Coxiella burnetii</italic> replication dependent on tissue</article-title>. <source>Infect Immun</source> (<year>2016</year>) <volume>84</volume>:<fpage>1815</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.01540-15</pub-id><?supplied-pmid 27068091?><pub-id pub-id-type="pmid">27068091</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahangian</surname><given-names>A</given-names></name><name><surname>Chow</surname><given-names>EK</given-names></name><name><surname>Tian</surname><given-names>X</given-names></name><name><surname>Kang</surname><given-names>JR</given-names></name><name><surname>Ghaffari</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>SY</given-names></name><etal/></person-group>
<article-title>Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice</article-title>. <source>J Clin Invest</source> (<year>2009</year>) <volume>119</volume>:<fpage>1910</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1172/JCI35412</pub-id><?supplied-pmid 19487810?><pub-id pub-id-type="pmid">19487810</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>S</given-names></name><name><surname>Davis</surname><given-names>KM</given-names></name><name><surname>Weiser</surname><given-names>JN</given-names></name></person-group>. <article-title>Synergistic stimulation of type I interferons during influenza virus coinfection promotes <italic>Streptococcus pneumoniae</italic> colonization in mice</article-title>. <source>J Clin Invest</source> (<year>2011</year>) <volume>121</volume>:<fpage>3657</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="doi">10.1172/JCI57762</pub-id><?supplied-pmid 21841308?><pub-id pub-id-type="pmid">21841308</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Moltedo</surname><given-names>B</given-names></name><name><surname>Moran</surname><given-names>TM</given-names></name></person-group>
<article-title>Type I interferon induction during influenza virus infection increases susceptibility to secondary <italic>Streptococcus pneumoniae</italic> infection by negative regulation of gammadelta T cells</article-title>. <source>J Virol</source> (<year>2012</year>) <volume>86</volume>:<fpage>12304</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.01269-12</pub-id><pub-id pub-id-type="pmid">22951826</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>B</given-names></name><name><surname>Robinson</surname><given-names>KM</given-names></name><name><surname>McHugh</surname><given-names>KJ</given-names></name><name><surname>Scheller</surname><given-names>EV</given-names></name><name><surname>Mandalapu</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Influenza-induced type I interferon enhances susceptibility to gram-negative and gram-positive bacterial pneumonia in mice</article-title>. <source>Am J Physiol Lung Cell Mol Physiol</source> (<year>2015</year>) <volume>15</volume>(<issue>309</issue>):<fpage>L158</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="doi">10.1152/ajplung.00338.2014</pub-id><?supplied-pmid 26001778?><pub-id pub-id-type="pmid">26001778</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isaacs</surname><given-names>A</given-names></name><name><surname>Lindenmann</surname><given-names>J</given-names></name></person-group>
<article-title>Virus interference. I. The interferon</article-title>. <source>Proc R Soc Lond B Biol Sci</source> (<year>1957</year>) <volume>12</volume>(<issue>147</issue>):<fpage>258</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="doi">10.1098/rspb.1957.0048</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Decker</surname><given-names>T</given-names></name><name><surname>Muller</surname><given-names>M</given-names></name><name><surname>Stockinger</surname><given-names>S</given-names></name></person-group>. <article-title>The yin and yang of type I interferon activity in bacterial infection</article-title>. <source>Nat Rev Immunol</source> (<year>2005</year>) <volume>5</volume>(<issue>9</issue>):<fpage>675</fpage>&#x02013;<lpage>87</lpage>.<pub-id pub-id-type="doi">10.1038/nri1684</pub-id><?supplied-pmid 16110316?><pub-id pub-id-type="pmid">16110316</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monroe</surname><given-names>KM</given-names></name><name><surname>McWhirter</surname><given-names>SM</given-names></name><name><surname>Vance</surname><given-names>RE</given-names></name></person-group>. <article-title>Induction of type I interferons by bacteria</article-title>. <source>Cell Microbiol</source> (<year>2010</year>) <volume>12</volume>:<fpage>881</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="doi">10.1111/j.1462-5822.2010.01478.x</pub-id><?supplied-pmid 20482555?><pub-id pub-id-type="pmid">20482555</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juang</surname><given-names>YT</given-names></name><name><surname>Lowther</surname><given-names>W</given-names></name><name><surname>Kellum</surname><given-names>M</given-names></name><name><surname>Au</surname><given-names>WC</given-names></name><name><surname>Lin</surname><given-names>R</given-names></name><name><surname>Hiscott</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>1998</year>) <volume>18</volume>(<issue>95</issue>):<fpage>9837</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.95.17.9837</pub-id><?supplied-pmid 9707562?><pub-id pub-id-type="pmid">9707562</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marie</surname><given-names>I</given-names></name><name><surname>Durbin</surname><given-names>JE</given-names></name><name><surname>Levy</surname><given-names>DE</given-names></name></person-group>. <article-title>Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7</article-title>. <source>EMBO J</source> (<year>1998</year>) <volume>17</volume>:<fpage>6660</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1093/emboj/17.22.6660</pub-id><?supplied-pmid 9822609?><pub-id pub-id-type="pmid">9822609</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade</surname><given-names>WA</given-names></name><name><surname>Agarwal</surname><given-names>S</given-names></name><name><surname>Mo</surname><given-names>S</given-names></name><name><surname>Shaffer</surname><given-names>SA</given-names></name><name><surname>Dillard</surname><given-names>JP</given-names></name><name><surname>Schmidt</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Type I interferon induction by <italic>Neisseria gonorrhoeae</italic>: dual requirement of cyclic GMP-AMP synthase and Toll-like receptor 4</article-title>. <source>Cell Rep</source> (<year>2016</year>) <volume>14</volume>(<issue>15</issue>):<fpage>2438</fpage>&#x02013;<lpage>48</lpage>.<pub-id pub-id-type="doi">10.1016/j.celrep.2016.05.030</pub-id><?supplied-pmid 27264171?><pub-id pub-id-type="pmid">27264171</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade</surname><given-names>WA</given-names></name><name><surname>Firon</surname><given-names>A</given-names></name><name><surname>Schmidt</surname><given-names>T</given-names></name><name><surname>Hornung</surname><given-names>V</given-names></name><name><surname>Fitzgerald</surname><given-names>KA</given-names></name><name><surname>Kurt-Jones</surname><given-names>EA</given-names></name><etal/></person-group>
<article-title>Group B streptococcus degrades cyclic-di-AMP to modulate STING-dependent type I interferon production</article-title>. <source>Cell Host Microbe</source> (<year>2016</year>) <volume>13</volume>(<issue>20</issue>):<fpage>49</fpage>&#x02013;<lpage>59</lpage>.<pub-id pub-id-type="doi">10.1016/j.chom.2016.06.003</pub-id><?supplied-pmid 27414497?><pub-id pub-id-type="pmid">27414497</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>AC</given-names></name><name><surname>Cai</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Franco</surname><given-names>LH</given-names></name><name><surname>Li</surname><given-names>XD</given-names></name><name><surname>Nair</surname><given-names>VR</given-names></name><etal/></person-group>
<article-title>Cyclic GMP-AMP synthase is an innate immune DNA sensor for <italic>Mycobacterium tuberculosis</italic></article-title>. <source>Cell Host Microbe</source> (<year>2015</year>) <volume>10</volume>(<issue>17</issue>):<fpage>820</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.chom.2015.05.005</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname><given-names>K</given-names></name><name><surname>Prabakaran</surname><given-names>T</given-names></name><name><surname>Laustsen</surname><given-names>A</given-names></name><name><surname>Jorgensen</surname><given-names>SE</given-names></name><name><surname>Rahbaek</surname><given-names>SH</given-names></name><name><surname>Jensen</surname><given-names>SB</given-names></name><etal/></person-group>
<article-title><italic>Listeria monocytogenes</italic> induces IFNbeta expression through an IFI16-, cGAS- and STING-dependent pathway</article-title>. <source>EMBO J</source> (<year>2014</year>) <volume>1</volume>(<issue>33</issue>):<fpage>1654</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="doi">10.15252/embj.201488029</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Storek</surname><given-names>KM</given-names></name><name><surname>Gertsvolf</surname><given-names>NA</given-names></name><name><surname>Ohlson</surname><given-names>MB</given-names></name><name><surname>Monack</surname><given-names>DM</given-names></name></person-group>. <article-title>cGAS and Ifi204 cooperate to produce type I IFNs in response to <italic>Francisella</italic> infection</article-title>. <source>J Immunol</source> (<year>2015</year>) <volume>1</volume>(<issue>194</issue>):<fpage>3236</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1402764</pub-id><?supplied-pmid 25710914?><pub-id pub-id-type="pmid">25710914</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wassermann</surname><given-names>R</given-names></name><name><surname>Gulen</surname><given-names>MF</given-names></name><name><surname>Sala</surname><given-names>C</given-names></name><name><surname>Perin</surname><given-names>SG</given-names></name><name><surname>Lou</surname><given-names>Y</given-names></name><name><surname>Rybniker</surname><given-names>J</given-names></name><etal/></person-group>
<article-title><italic>Mycobacterium tuberculosis</italic> differentially activates cGAS- and inflammasome-dependent intracellular immune responses through ESX-1</article-title>. <source>Cell Host Microbe</source> (<year>2015</year>) <volume>10</volume>(<issue>17</issue>):<fpage>799</fpage>&#x02013;<lpage>810</lpage>.<pub-id pub-id-type="doi">10.1016/j.chom.2015.05.003</pub-id><?supplied-pmid 26048138?><pub-id pub-id-type="pmid">26048138</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>RO</given-names></name><name><surname>Bell</surname><given-names>SL</given-names></name><name><surname>MacDuff</surname><given-names>DA</given-names></name><name><surname>Kimmey</surname><given-names>JM</given-names></name><name><surname>Diner</surname><given-names>EJ</given-names></name><name><surname>Olivas</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>The cytosolic sensor cGAS detects <italic>Mycobacterium tuberculosis</italic> DNA to induce type I interferons and activate autophagy</article-title>. <source>Cell Host Microbe</source> (<year>2015</year>) <volume>10</volume>(<issue>17</issue>):<fpage>811</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.chom.2015.05.004</pub-id><?supplied-pmid 26048136?><pub-id pub-id-type="pmid">26048136</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woodward</surname><given-names>JJ</given-names></name><name><surname>Iavarone</surname><given-names>AT</given-names></name><name><surname>Portnoy</surname><given-names>DA</given-names></name></person-group>. <article-title>c-di-AMP secreted by intracellular <italic>Listeria monocytogenes</italic> activates a host type I interferon response</article-title>. <source>Science</source> (<year>2010</year>) <volume>25</volume>(<issue>328</issue>):<fpage>1703</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1126/science.1189801</pub-id><?supplied-pmid 20508090?><pub-id pub-id-type="pmid">20508090</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fieber</surname><given-names>C</given-names></name><name><surname>Janos</surname><given-names>M</given-names></name><name><surname>Koestler</surname><given-names>T</given-names></name><name><surname>Gratz</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>XD</given-names></name><name><surname>Castiglia</surname><given-names>V</given-names></name><etal/></person-group>
<article-title>Innate immune response to <italic>Streptococcus pyogenes</italic> depends on the combined activation of TLR13 and TLR2</article-title>. <source>PLoS One</source> (<year>2015</year>) <volume>10</volume>:<fpage>e0119727</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0119727</pub-id><?supplied-pmid 25756897?><pub-id pub-id-type="pmid">25756897</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hidmark</surname><given-names>A</given-names></name><name><surname>von Saint Paul</surname><given-names>A</given-names></name><name><surname>Dalpke</surname><given-names>AH</given-names></name></person-group>. <article-title>Cutting edge: TLR13 is a receptor for bacterial RNA</article-title>. <source>J Immunol</source> (<year>2012</year>) <volume>15</volume>(<issue>189</issue>):<fpage>2717</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1200898</pub-id><?supplied-pmid 22896636?><pub-id pub-id-type="pmid">22896636</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>XD</given-names></name><name><surname>Chen</surname><given-names>ZJ</given-names></name></person-group>. <article-title>Sequence specific detection of bacterial 23S ribosomal RNA by TLR13</article-title>. <source>Elife</source> (<year>2012</year>) <volume>1</volume>:<fpage>e00102</fpage>.<pub-id pub-id-type="doi">10.7554/eLife.00102</pub-id><?supplied-pmid 23110254?><pub-id pub-id-type="pmid">23110254</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oldenburg</surname><given-names>M</given-names></name><name><surname>Kruger</surname><given-names>A</given-names></name><name><surname>Ferstl</surname><given-names>R</given-names></name><name><surname>Kaufmann</surname><given-names>A</given-names></name><name><surname>Nees</surname><given-names>G</given-names></name><name><surname>Sigmund</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modification</article-title>. <source>Science</source> (<year>2012</year>) <volume>31</volume>(<issue>337</issue>):<fpage>1111</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1126/science.1220363</pub-id><?supplied-pmid 22821982?><pub-id pub-id-type="pmid">22821982</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergstrom</surname><given-names>B</given-names></name><name><surname>Aune</surname><given-names>MH</given-names></name><name><surname>Awuh</surname><given-names>JA</given-names></name><name><surname>Kojen</surname><given-names>JF</given-names></name><name><surname>Blix</surname><given-names>KJ</given-names></name><name><surname>Ryan</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>TLR8 senses <italic>Staphylococcus aureus</italic> RNA in human primary monocytes and macrophages and induces IFN-beta production via a TAK1-IKKbeta-IRF5 signaling pathway</article-title>. <source>J Immunol</source> (<year>2015</year>) <volume>1</volume>(<issue>195</issue>):<fpage>1100</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1403176</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eigenbrod</surname><given-names>T</given-names></name><name><surname>Pelka</surname><given-names>K</given-names></name><name><surname>Latz</surname><given-names>E</given-names></name><name><surname>Kreikemeyer</surname><given-names>B</given-names></name><name><surname>Dalpke</surname><given-names>AH</given-names></name></person-group>. <article-title>TLR8 senses bacterial RNA in human monocytes and plays a nonredundant role for recognition of <italic>Streptococcus pyogenes</italic></article-title>. <source>J Immunol</source> (<year>2015</year>) <volume>1</volume>(<issue>195</issue>):<fpage>1092</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1403173</pub-id><?supplied-pmid 26101323?><pub-id pub-id-type="pmid">26101323</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kruger</surname><given-names>A</given-names></name><name><surname>Oldenburg</surname><given-names>M</given-names></name><name><surname>Chebrolu</surname><given-names>C</given-names></name><name><surname>Beisser</surname><given-names>D</given-names></name><name><surname>Kolter</surname><given-names>J</given-names></name><name><surname>Sigmund</surname><given-names>AM</given-names></name><etal/></person-group>
<article-title>Human TLR8 senses UR/URR motifs in bacterial and mitochondrial RNA</article-title>. <source>EMBO Rep</source> (<year>2015</year>) <volume>16</volume>(<issue>12</issue>):<fpage>1656</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.15252/embr.201540861</pub-id><?supplied-pmid 26545385?><pub-id pub-id-type="pmid">26545385</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kagan</surname><given-names>JC</given-names></name><name><surname>Su</surname><given-names>T</given-names></name><name><surname>Horng</surname><given-names>T</given-names></name><name><surname>Chow</surname><given-names>A</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name><name><surname>Medzhitov</surname><given-names>R</given-names></name></person-group>. <article-title>TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta</article-title>. <source>Nat Immunol</source> (<year>2008</year>) <volume>9</volume>:<fpage>361</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1038/ni1569</pub-id><?supplied-pmid 18297073?><pub-id pub-id-type="pmid">18297073</pub-id></mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aubry</surname><given-names>C</given-names></name><name><surname>Corr</surname><given-names>SC</given-names></name><name><surname>Wienerroither</surname><given-names>S</given-names></name><name><surname>Goulard</surname><given-names>C</given-names></name><name><surname>Jones</surname><given-names>R</given-names></name><name><surname>Jamieson</surname><given-names>AM</given-names></name><etal/></person-group>
<article-title>Both TLR2 and TRIF contribute to interferon-beta production during <italic>Listeria</italic> infection</article-title>. <source>PLoS One</source> (<year>2012</year>) <volume>7</volume>:<fpage>e33299</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0033299</pub-id><pub-id pub-id-type="pmid">22432012</pub-id></mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dietrich</surname><given-names>N</given-names></name><name><surname>Lienenklaus</surname><given-names>S</given-names></name><name><surname>Weiss</surname><given-names>S</given-names></name><name><surname>Gekara</surname><given-names>NO</given-names></name></person-group>. <article-title>Murine toll-like receptor 2 activation induces type I interferon responses from endolysosomal compartments</article-title>. <source>PLoS One</source> (<year>2010</year>) <volume>20</volume>(<issue>5</issue>):<fpage>e10250</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0010250</pub-id><?supplied-pmid 20422028?><pub-id pub-id-type="pmid">20422028</pub-id></mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stack</surname><given-names>J</given-names></name><name><surname>Doyle</surname><given-names>SL</given-names></name><name><surname>Connolly</surname><given-names>DJ</given-names></name><name><surname>Reinert</surname><given-names>LS</given-names></name><name><surname>O&#x02019;Keeffe</surname><given-names>KM</given-names></name><name><surname>McLoughlin</surname><given-names>RM</given-names></name><etal/></person-group>
<article-title>TRAM is required for TLR2 endosomal signaling to type I IFN induction</article-title>. <source>J Immunol</source> (<year>2014</year>) <volume>15</volume>(<issue>193</issue>):<fpage>6090</fpage>&#x02013;<lpage>102</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1401605</pub-id><?supplied-pmid 25385819?><pub-id pub-id-type="pmid">25385819</pub-id></mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>AK</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Fortune</surname><given-names>SM</given-names></name><name><surname>Coulombe</surname><given-names>F</given-names></name><name><surname>Behr</surname><given-names>MA</given-names></name><etal/></person-group>
<article-title>NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to <italic>Mycobacterium tuberculosis</italic></article-title>. <source>PLoS Pathog</source> (<year>2009</year>) <volume>5</volume>:<fpage>e1000500</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1000500</pub-id><?supplied-pmid 19578435?><pub-id pub-id-type="pmid">19578435</pub-id></mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dresing</surname><given-names>P</given-names></name><name><surname>Borkens</surname><given-names>S</given-names></name><name><surname>Kocur</surname><given-names>M</given-names></name><name><surname>Kropp</surname><given-names>S</given-names></name><name><surname>Scheu</surname><given-names>S</given-names></name></person-group>
<article-title>A fluorescence reporter model defines &#x0201c;Tip-DCs&#x0201d; as the cellular source of interferon beta in murine listeriosis</article-title>. <source>PLoS One</source> (<year>2010</year>) <volume>5</volume>:<fpage>e15567</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0015567</pub-id><pub-id pub-id-type="pmid">21179567</pub-id></mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solodova</surname><given-names>E</given-names></name><name><surname>Jablonska</surname><given-names>J</given-names></name><name><surname>Weiss</surname><given-names>S</given-names></name><name><surname>Lienenklaus</surname><given-names>S</given-names></name></person-group>
<article-title>Production of IFN-beta during <italic>Listeria monocytogenes</italic> infection is restricted to monocyte/macrophage lineage</article-title>. <source>PLoS One</source> (<year>2011</year>) <volume>6</volume>:<fpage>e18543</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0018543</pub-id><pub-id pub-id-type="pmid">21494554</pub-id></mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stockinger</surname><given-names>S</given-names></name><name><surname>Kastner</surname><given-names>R</given-names></name><name><surname>Kernbauer</surname><given-names>E</given-names></name><name><surname>Pilz</surname><given-names>A</given-names></name><name><surname>Westermayer</surname><given-names>S</given-names></name><name><surname>Reutterer</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Characterization of the interferon-producing cell in mice infected with <italic>Listeria monocytogenes</italic></article-title>. <source>PLoS Pathog</source> (<year>2009</year>) <volume>5</volume>:<fpage>e1000355</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1000355</pub-id><?supplied-pmid 19325882?><pub-id pub-id-type="pmid">19325882</pub-id></mixed-citation></ref><ref id="B68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koltai</surname><given-names>M</given-names></name><name><surname>Meos</surname><given-names>E</given-names></name></person-group>
<article-title>Inhibition of the acute inflammatory response by interferon inducers</article-title>. <source>Nature</source> (<year>1973</year>) <volume>20</volume>(<issue>242</issue>):<fpage>525</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1038/242525a0</pub-id></mixed-citation></ref><ref id="B69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>EY</given-names></name><name><surname>Guo</surname><given-names>B</given-names></name><name><surname>Doyle</surname><given-names>SE</given-names></name><name><surname>Cheng</surname><given-names>G</given-names></name></person-group>. <article-title>Cutting edge: involvement of the type I IFN production and signaling pathway in lipopolysaccharide-induced IL-10 production</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>1</volume>(<issue>178</issue>):<fpage>6705</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.178.11.6705</pub-id><?supplied-pmid 17513714?><pub-id pub-id-type="pmid">17513714</pub-id></mixed-citation></ref><ref id="B70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>MP</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>McNab</surname><given-names>FW</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Bloch</surname><given-names>SA</given-names></name><name><surname>Oni</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title>. <source>Nature</source> (<year>2010</year>) <volume>19</volume>(<issue>466</issue>):<fpage>973</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1038/nature09247</pub-id></mixed-citation></ref><ref id="B71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreira-Teixeira</surname><given-names>L</given-names></name><name><surname>Sousa</surname><given-names>J</given-names></name><name><surname>McNab</surname><given-names>FW</given-names></name><name><surname>Torrado</surname><given-names>E</given-names></name><name><surname>Cardoso</surname><given-names>F</given-names></name><name><surname>Machado</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Type I IFN inhibits alternative macrophage activation during <italic>Mycobacterium tuberculosis</italic> infection and leads to enhanced protection in the absence of IFN-gamma signaling</article-title>. <source>J Immunol</source> (<year>2016</year>) <volume>197</volume>(<issue>12</issue>):<fpage>4714</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1600584</pub-id><pub-id pub-id-type="pmid">27849167</pub-id></mixed-citation></ref><ref id="B72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrero</surname><given-names>JA</given-names></name><name><surname>Calderon</surname><given-names>B</given-names></name><name><surname>Unanue</surname><given-names>ER</given-names></name></person-group>. <article-title>Lymphocytes are detrimental during the early innate immune response against <italic>Listeria monocytogenes</italic></article-title>. <source>J Exp Med</source> (<year>2006</year>) <volume>17</volume>(<issue>203</issue>):<fpage>933</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20060045</pub-id><?supplied-pmid 16549598?><pub-id pub-id-type="pmid">16549598</pub-id></mixed-citation></ref><ref id="B73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stockinger</surname><given-names>S</given-names></name><name><surname>Materna</surname><given-names>T</given-names></name><name><surname>Stoiber</surname><given-names>D</given-names></name><name><surname>Bayr</surname><given-names>L</given-names></name><name><surname>Steinborn</surname><given-names>R</given-names></name><name><surname>Kolbe</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Production of type I IFN sensitizes macrophages to cell death induced by <italic>Listeria monocytogenes</italic></article-title>. <source>J Immunol</source> (<year>2002</year>) <volume>1</volume>(<issue>169</issue>):<fpage>6522</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.169.11.6522</pub-id><?supplied-pmid 12444163?><pub-id pub-id-type="pmid">12444163</pub-id></mixed-citation></ref><ref id="B74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>BH</given-names></name><name><surname>Chee</surname><given-names>JD</given-names></name><name><surname>Bradfield</surname><given-names>CJ</given-names></name><name><surname>Park</surname><given-names>ES</given-names></name><name><surname>Kumar</surname><given-names>P</given-names></name><name><surname>MacMicking</surname><given-names>JD</given-names></name></person-group>. <article-title>Interferon-induced guanylate-binding proteins in inflammasome activation and host defense</article-title>. <source>Nat Immunol</source> (<year>2016</year>) <volume>17</volume>:<fpage>481</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/ni.3440</pub-id><?supplied-pmid 27092805?><pub-id pub-id-type="pmid">27092805</pub-id></mixed-citation></ref><ref id="B75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Man</surname><given-names>SM</given-names></name><name><surname>Place</surname><given-names>DE</given-names></name><name><surname>Kuriakose</surname><given-names>T</given-names></name><name><surname>Kanneganti</surname><given-names>TD</given-names></name></person-group>
<article-title>Interferon-inducible guanylate-binding proteins at the interface of cell-autonomous immunity and inflammasome activation</article-title>. <source>J Leukoc Biol</source> (<year>2016</year>).<pub-id pub-id-type="doi">10.1189/jlb.4MR0516-223R</pub-id></mixed-citation></ref><ref id="B76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meunier</surname><given-names>E</given-names></name><name><surname>Dick</surname><given-names>MS</given-names></name><name><surname>Dreier</surname><given-names>RF</given-names></name><name><surname>Schurmann</surname><given-names>N</given-names></name><name><surname>Kenzelmann Broz</surname><given-names>D</given-names></name><name><surname>Warming</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases</article-title>. <source>Nature</source> (<year>2014</year>) <volume>15</volume>(<issue>509</issue>):<fpage>366</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1038/nature13157</pub-id><?supplied-pmid 24739961?><pub-id pub-id-type="pmid">24739961</pub-id></mixed-citation></ref><ref id="B77"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meunier</surname><given-names>E</given-names></name><name><surname>Wallet</surname><given-names>P</given-names></name><name><surname>Dreier</surname><given-names>RF</given-names></name><name><surname>Costanzo</surname><given-names>S</given-names></name><name><surname>Anton</surname><given-names>L</given-names></name><name><surname>Ruhl</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Guanylate-binding proteins promote activation of the AIM2 inflammasome during infection with <italic>Francisella novicida</italic></article-title>. <source>Nat Immunol</source> (<year>2015</year>) <volume>16</volume>:<fpage>476</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1038/ni.3119</pub-id><?supplied-pmid 25774716?><pub-id pub-id-type="pmid">25774716</pub-id></mixed-citation></ref><ref id="B78"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uchiyama</surname><given-names>S</given-names></name><name><surname>Keller</surname><given-names>N</given-names></name><name><surname>Schlaepfer</surname><given-names>E</given-names></name><name><surname>Grube</surname><given-names>C</given-names></name><name><surname>Schuepbach</surname><given-names>RA</given-names></name><name><surname>Speck</surname><given-names>RF</given-names></name><etal/></person-group>
<article-title>Interferon alpha-enhanced clearance of group A <italic>Streptococcus</italic> despite neutropenia</article-title>. <source>J Infect Dis</source> (<year>2016</year>) <volume>15</volume>(<issue>214</issue>):<fpage>321</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/jiw157</pub-id></mixed-citation></ref></